Lipocine
Lipocine $LPCN 4th Submission Run-up Lipocine Inc $LPCN has a PDUFA on Aug. 28 for Tlando, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed to help restore normal testosterone levels in hypogonadal men.
Lipocine Announces Derivative Suit Was Dismissed 7/31/2020
www.prnewswire.com
I really like how this chart is setting up over the $1.60 level if volume continues. There is a lot of short squeeze potential in the name, and always manage your risk.
